Toxicity Profile of Commonly Used Anti-Inflammatory Drugs in Geriatrics

Authors

  • Talal M. Ziad Alhouzani Department of Pharmacology, Punjab University College of Pharmacy, University of the Punjab, Lahore-54000, Pakistan

Keywords:

Anti-inflammatory agent, Comorbidity, Geriatrics, Inflammation

Abstract

Background: Anti-inflammatory drugs are commonly used in geriatrics. Geriatrics usually encounter problems of pain and inflammation and are more vulnerable to the toxicity of drugs as compared to young patients. In this review, we aimed to find out the toxic profile of drugs and the pharmacotherapy considerations for geriatric care.

Methods: The electronic databases like Google Scholar, PubMed, ScienceDirect, and different related text books of recent edition were searched using specific keywords for preparing this narrative review. Related experts in the field were also consulted. Papers published in English language were included in the review.

Results: The diseases geriatrics mostly suffered from are osteoarthritis (OA), ankylosing spondylitis, carcinoma, and other degenerative disorders that require anti-inflammatory medicines. Non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids are mostly used agents for the treatment of inflammation in such population. As the pharmacokinetics of drugs get altered due to alteration in body physiology in geriatrics, the pharmacodynamics also gets affected, and hence toxicity ensues even with normal dose. Depending upon the nature of the drugs, presence of comorbidity, and poly-pharmacy; gastrointestinal, renal, and cardiovascular toxicities occur. Due to this reason, utmost care should be taken for pharmacotherapy practice in geriatrics.

Conclusion: In geriatrics, the anti-inflammatory drugs should be used rationally for the shortest duration possible at the lowest effective dose. The careful evaluation of the beneficial and potential risks of the agents and pharmacovigilance must be considered for pharmacotherapy practice in such populations.

Downloads

Download data is not yet available.
Abstract
311
pdf
296

Downloads

Published

2020-12-30

How to Cite

Alhouzani, T. M. Z. (2020). Toxicity Profile of Commonly Used Anti-Inflammatory Drugs in Geriatrics. Europasian Journal of Medical Sciences, 2(2), 114–123. Retrieved from https://nepjol.info./index.php/ejms/article/view/33868

Issue

Vol. 2 No. 2 (2020): Europasian Journal of Medical Sciences (EJMS) | 2020 (July - December) Issue 3

Section

Review Articles

License

The author(s) retain the ownership of the copyrights for their work published in EJMS without any restrictions. Upon submission, the author(s) grants EJMS a license to publish, including to display, store, copy, and reuse the published content.

License to Publish
By submitting a manuscript to EJMS, the author(s) grant the journal a non-exclusive license to:

  • Publish and distribute the content in all formats, media, and platforms (both existing and future), while identifying EJMS as the original publisher.
  • Reproduce, display, and store the content in both print and online formats, including institutional and digital repositories.
  • Translate, adapt, and summarize the work, including reprints, extracts, and abstracts.
  • Develop derivative works based on the original content.
  • Include the work in electronic databases and provide links to third-party materials.

Creative Commons Licensing
In addition to EJMS’s publishing rights, authors grant third parties the right to use, share, and distribute their work under the Creative Commons Attribution 4.0 (CC BY 4.0) International License. This allows unrestricted use of the content, provided proper attribution is given to the original author(s) and the journal.